ABEONA THERAPEUTICS INC. Increase (Decrease) in Inventories
ABEONA THERAPEUTICS INC. (ABEO) reported Increase (Decrease) in Inventories of $428.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInInventories · last filed 2026-08-13
- ABEONA THERAPEUTICS INC. increase (decrease) in inventories for the quarter ending 2026-06-30 was -$133.00K.
- ABEONA THERAPEUTICS INC. increase (decrease) in inventories for the quarter ending 2026-03-31 was $561.00K.
- ABEONA THERAPEUTICS INC. increase (decrease) in inventories for the quarter ending 2025-12-31 was $643.00K.
- ABEONA THERAPEUTICS INC. increase (decrease) in inventories for the quarter ending 2025-09-30 was $2.16M.
- ABEONA THERAPEUTICS INC. increase (decrease) in inventories for fiscal 2025 was $5.49M.
- ABEONA THERAPEUTICS INC. increase (decrease) in inventories for fiscal 2014 was $0.00.
- ABEONA THERAPEUTICS INC. increase (decrease) in inventories for fiscal 2013 was -$194.00K, a 551.16% decline from fiscal 2012.
- ABEONA THERAPEUTICS INC. increase (decrease) in inventories for fiscal 2012 was $43.00K, a 71.52% decline from fiscal 2011.
| Period end | Increase (Decrease) in Inventories 3 month | Increase (Decrease) in Inventories 6 month | Increase (Decrease) in Inventories 9 month | Increase (Decrease) in Inventories 9 month as first filed | Increase (Decrease) in Inventories 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | -$133.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $428.00K 10-Q · filed 2026-08-13 | $1.07M derived: sum of 3 quarters · filed 2026-08-13 | $3.23M derived: sum of 4 quarters · filed 2026-08-13 | |
| 2026-03-31 | $561.00K 10-Q · filed 2026-05-13 | $1.20M derived: sum of 2 quarters · filed 2026-05-13 | $3.37M derived: sum of 3 quarters · filed 2026-05-13 | ||
| 2025-12-31 | $643.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-17 | $2.81M derived: sum of 2 quarters · filed 2026-03-17 | $5.49M 10-K · filed 2026-03-17 | ||
| 2025-09-30 | $2.16M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $4.85M 10-Q · filed 2025-11-12 | |||
| 2025-06-30 | $2.69M 10-Q · filed 2026-08-13 | ||||
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-31 | $0.00 derived: sum of 2 quarters · filed 2015-03-31 | $0.00 derived: sum of 3 quarters · filed 2015-03-31 | $0.00 10-K · filed 2015-03-31 | |
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-14 | $0.00 derived: sum of 2 quarters · filed 2014-11-14 | $0.00 10-Q · filed 2014-11-14 | $0.00 derived: sum of 4 quarters · filed 2015-03-31 | |
| 2014-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-14 | $0.00 10-Q · filed 2014-08-14 | $0.00 derived: sum of 3 quarters · filed 2015-03-31 | $0.00 derived: sum of 4 quarters · filed 2015-03-31 | |
| 2014-03-31 | $0.00 10-Q · filed 2014-05-12 | $0.00 derived: sum of 2 quarters · filed 2015-03-31 | $0.00 derived: sum of 3 quarters · filed 2015-03-31 | -$150.00K derived: sum of 4 quarters · filed 2015-03-31 | |
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-31 | $0.00 derived: sum of 2 quarters · filed 2015-03-31 | -$150.00K derived: sum of 3 quarters · filed 2015-03-31 | -$194.00K 10-K · filed 2015-03-31 | |
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-14 | -$150.00K derived: sum of 2 quarters · filed 2014-11-14 | -$194.00K 10-Q · filed 2014-11-14 | -$236.00K derived: sum of 4 quarters · filed 2014-11-14 | |
| 2013-06-30 | -$150.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-14 | -$194.00K 10-Q · filed 2014-08-14 | -$236.00K derived: sum of 3 quarters · filed 2014-08-14 | -$281.00K derived: sum of 4 quarters · filed 2014-08-14 | |
| 2013-03-31 | -$44.00K 10-Q · filed 2014-05-12 | -$86.00K derived: sum of 2 quarters · filed 2014-05-12 | -$131.00K derived: sum of 3 quarters · filed 2014-05-12 | $53.00K derived: sum of 4 quarters · filed 2014-05-12 | |
| 2012-12-31 | -$42.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-26 | -$87.00K derived: sum of 2 quarters · filed 2014-03-26 | $97.00K derived: sum of 3 quarters · filed 2014-03-26 | $43.00K 10-K · filed 2014-03-26 | |
| 2012-09-30 | -$45.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-14 | $139.00K derived: sum of 2 quarters · filed 2013-11-14 | $85.00K 10-Q · filed 2013-11-14 | $44.00K derived: sum of 4 quarters · filed 2013-11-14 | |
| 2012-06-30 | $184.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-14 | $130.00K 10-Q · filed 2013-08-14 | $89.00K derived: sum of 3 quarters · filed 2013-08-14 | $281.00K derived: sum of 4 quarters · filed 2013-08-14 | |
| 2012-03-31 | -$54.00K 10-Q · filed 2013-05-15 | -$95.00K derived: sum of 2 quarters · filed 2013-05-15 | $97.00K derived: sum of 3 quarters · filed 2013-05-15 | $97.00K derived: sum of 4 quarters · filed 2013-05-15 | |
| 2011-12-31 | -$41.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-20 | $151.00K derived: sum of 2 quarters · filed 2013-03-20 | $151.00K derived: sum of 3 quarters · filed 2013-03-20 | $151.00K 10-K · filed 2013-03-20 | |
| 2011-09-30 | $192.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-14 | $192.00K derived: sum of 2 quarters · filed 2012-11-14 | $192.00K 10-Q · filed 2012-11-14 | -$192.00K 10-Q · filed 2011-11-14 | |
| 2011-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-14 | $0.00 10-Q · filed 2012-08-14 | |||
| 2011-03-31 | $0.00 10-Q · filed 2012-05-15 | ||||
| 2010-09-30 | $0.00 10-Q · filed 2011-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |